Skip to main content

Closed

ENSC: Ensysce Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-2.8% / yr

Operating margin-813.9%

ROIC2797.0%

Financially safe

Stretched

Debt / equity-0.72×

Interest coverage-628.4×

Current ratio0.71×

Ensysce Biosciences, Inc.

ENSCNASDAQ Capital Market·USD·Closed

Ensysce Biosciences, Inc.

ENSCNASDAQ·USD·Closed

$0.25

−1.56%

$0.25

−$0.00 (1.56%)

52W Range

1thpctl

Volume

0.11×avg

Mkt Cap

2.35MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.11×avg

Market Cap

2.35MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings